Fraser, Christopher,Kishimoto, Takashi Kei,Maldonado, Roberto A.
申请号：
AU2017245278
公开号：
AU2017245278A1
申请日:
2017.10.09
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017245278A120171102.pdf#####ABSTRACT Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class I-restricted and/or MHC Class II-restricted epitopes associated with undesired CD8+ T cell responses and immunosuppressants that provide tolerogenic immune responses against antigens that comprise the epitopes. See Fig. 5.WO 2012/149265 PCT/US2012/035378 3/3 100Ln 80S6020 N/A 0 LnC)L z z D- No imm IMOVA±CpG sc Fig. 4 1.5Q u0.50 0.0 --in0>； z Fig. 5
